SLC2A1 and medullary breast carcinoma: The Curtis Breast dataset [24] indicated that compared to normal samples, SLC2A1 overexpression is also found in medullary breast carcinoma (fold change = 2.728), in mucinous breast carcinoma (fold change = 2.100) and in invasive breast carcinoma (fold change = 2.317).